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Plasma Selenium Biomarkers in Low Income Black and
White Americans from the Southeastern United States
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Abstract
Biomarkers of selenium are necessary for assessing selenium status in humans, since soil variation hinders estimation of
selenium intake from foods. In this study, we measured the concentration of plasma selenium, selenoprotein P (SEPP1), and
glutathione peroxidase (GPX3) activity and their interindividual differences in 383 low-income blacks and whites selected
from a stratified random sample of adults aged 40–79 years, who were participating in a long-term cohort study in the
southeastern United States (US). We assessed the utility of these biomarkers to determine differences in selenium status and
their association with demographic, socio-economic, dietary, and other indicators. Dietary selenium intake was assessed
using a validated food frequency questionnaire designed for the cohort, matched with region-specific food selenium
content, and compared with the US Recommended Dietary Allowances (RDA) set at 55 mg/day. We found that SEPP1, a
sensitive biomarker of selenium nutritional status, was significantly lower among blacks than whites (mean 4.461.1 vs.
4.761.0 mg/L, p = 0.006), with blacks less than half as likely to have highest vs. lowest quartile SEPP1 concentration (Odds
Ratio (OR) 0.4, 95% Confidence Interval (CI) 0.2–0.8). The trend in a similar direction was observed for plasma selenium
among blacks and whites, (mean 115615.1 vs. 118617.7 mg/L, p = 0.08), while GPX3 activity did not differ between blacks
and whites (136633.3 vs. 132633.5 U/L, p = 0.320). Levels of the three biomarkers were not correlated with estimated
dietary selenium intake, except for SEPP1 among 10% of participants with the lowest selenium intake (#57 mg/day). The
findings suggest that SEPP1 may be an effective biomarker of selenium status and disease risk in adults and that low
selenium status may disproportionately affect black and white cohort participants.
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significant reduction in overall cancer mortality among adults
supplemented with a combination of selenium (as 50 mg selenium
yeast/day), beta carotene and vitamin E [18]. But in the SELECT
trial conducted in the US, the hypothesized reduction in the
incidence of prostate cancer was not found among those
supplemented with 200 mg selenium/day as selenomethionine
[19].
Selenium is widely distributed in foods, but its availability
depends on the concentration of selenium in the soil. Where there
are low selenium soils, selenium deficiency has been demonstrated,
especially in China [20], South Africa [21], Poland [22], [23] and
other countries [4], [16]. Deficiency is believed not to exist in the
US because of the wide distribution of selenium-rich foods.
However, the level of selenium in soils in the southeast is lower
than in the other parts of the US [24–26]. The southeast also
comprises a geographic area where the largest numbers of blacks
and poor reside [27], and where cancer mortality rates are higher
than the rest of the country [28].

Introduction
Over the past eight decades, there has been a great increase in
the scientific literature on the health effects of selenium – from its
first discovery as a toxic agent in large animals [1], to its
recognition as an essential nutrient [2], [3], and to its possible
involvement in conditions such as cancer, cardiovascular disease,
certain viral infections, immune function, and mood [1], [4–6].
Selenium is now known to exist in different tissues and fluids of the
body, and in different forms [7], [8], making measurement and
interpretation of selenium status difficult.
Selenium has been implicated as a possible inhibitor of a variety
of cancers, key among them being prostate [9], colorectal [10],
lung [11], esophageal and gastrointestinal cancers [12]. Each of
these cancers has a higher incidence and mortality rate in blacks as
compared with whites [13], but attempts to correlate these rates
with plasma selenium have produced variable results, so, the role
of selenium in carcinogenesis, cancer prevention, and cancer
disparities has yet to be established [14–17]. In the two largest
selenium chemoprevention trials, one in China showed a
PLOS ONE | www.plosone.org
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It is thought that levels of selenium needed to protect against
cancer may be higher than those needed to correct nutrition
deficiency [29], [30]. Since the difference between selenium
requirement and toxicity is narrow, it is extremely important to
define the limits of selenium nutriture [8]. Most frequently
measured markers include plasma selenium, SEPP1, and GPX3,
which are responsive to changes in selenium intake [8], [20], [31–
34], and demonstrate functionality of selenium biologically.
However, more work is needed in different population groups
[8]. Currently published information on the selenium status
among low-income residents (both blacks and whites) in the
southeastern US is limited.
The purposes of this study were: (1) to measure differences in
plasma biomarkers of selenium status (selenium, SEPP1, and
GPX3) among low-income blacks and whites selected from a
stratified random sample of adults aged 40–79 years, who were
participating in a long-term cohort study in the southeastern US,
and (2), to determine the utility of plasma biomarkers in assessing
selenium status and related demographic, socioeconomic, dietary,
and other indicators.

Table 1. Characteristics of the SCCS sample.

Demographics Variables

Whites

Blacks

Gender
Male

96 (50)

94 (49)

Female

95 (50)

98 (51)

Age Group (years)
40 to 49

67 (35)

101 (53)

50 to 59

65 (34)

57 (30)

60 to 79

59 (31)

34 (18)

, High School

55 (29)

69 (36)

High School

66 (35)

67 (35)

.High School

70 (37)

56 (29)

Education

Household Annual Income

Materials and Methods
Ethics Statement
Study protocols were approved by Institutional Review Boards
at Meharry Medical College and Vanderbilt University and
participants provided written informed consent administered by
trained interviewers.

Less than $15,000 116 (61)

113 (59)

$15,000 –
,$25,000

40 (21)

44 (23)

$25,000 –
,$50,000

21 (11)

31 (16)

$50,000 or more

13 (7)

2 (1)

Missing

1 (1)

2 (1)

18.3 – 24.9

63 (33)

63 (33)

25.0 – 29.9

65 (34)

65 (34)

$30.0

63 (33)

64 (33)

Whites

Blacks

63 (33)

64 (33)

Former Smoking

65 (34)

65 (34)

Current Smoking

63 (33)

63 (33)

BMI (kg/m2)

Populations
The SCCS is
a prospective cohort study conducted in the southeastern US with
a major goal to understand the causes of cancer and other key
health disparities among blacks and whites. Details of the methods
have been described elsewhere [35, [36]. In brief, adults were
recruited from community health centers (CHCs) across a 12-state
region (Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee,
Virginia, and West Virginia). Since CHCs provide basic and
preventive health care in underserved areas, most of the black and
white enrollees were of low socio-economic status [37]. Eligible
participants were 40 to 79 years of age, had not been diagnosed
with or under treatment for cancer for at least the past year, and
were English speaking. After consenting, participants were
administered a comprehensive computer-assisted interview by a
trained interviewer asking for demographic, anthropometric,
medical history, diet, physical activity, use of tobacco, alcohol,
medications, and other characteristics. Biologic specimens (blood,
saliva, and/or urine samples) were provided by approximately
90% of the cohort participants recruited from the CHCs. Blood
was provided by 54%, with generally similar characteristics of
those with vs. those without blood donation [36].
To help characterize the cohort, a series of biomarker studies
were carried out using biospecimens from a stratified random
sample of SCCS participants [38–41]. A 2626363 factorial
design was used to draw the sample and ensure even balance by
race (black/white), sex (male/female), smoking (never/former/
current), and body mass index (BMI) (,25.0, 25.0–29.9, $30 kg/
m2) so that differences in biomarkers between these groups could
be detected with substantially enhanced statistical power. For the
selenium biomarker studies reported herein, 383 participants were
included (Table 1).
Southern Community Cohort Study (SCCS).

Lifestyle Variables
Cigarette smoking
Non Smoking

Fruit and vegetable intake (times/day)
0–1

30 (16)

2–4

99 (52)

22 (11)
79 (41)

At least 5

62 (32)

91 (47)

0–1

111 (58)

83 (43)

2–4

75 (39)

87 (45)

At least 5

5 (3)

22 (11)

Yes

108 (57)

79 (41)

No

83 (43)

113 (59)

Meat and fish intake (times/day)

Living on farm

Outcome Variables

Whites

Blacks

Se

188 (98)

190 (99)

3 (2)

2 (1)

191 (100)

192 (100)

184 (96)

182 (95)

7 (4)

10 (5)

Missing
SEPP1
Missing
GPX3
Missing

BMI - Body Mass Index; SEPP1 - Selenoprotein P; GPX3 - Glutathione Peroxidase.
doi:10.1371/journal.pone.0084972.t001

The Third National Health and Nutrition Examination
Survey (NHANES III). To investigate how SCCS selenium
PLOS ONE | www.plosone.org
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results compared with other population data, and to compare
newly assessed selenium status for the general population of the
southern region, we accessed data from NHANES III (1988–1994)
(NHANES III, series 11, no. 1A, http://www.cdc.gov/nchs/
nhanes/nh3data.htm#1a). NHANES III is a US nationwide
survey conducted by the National Center for Health Statistics of
the Centers for Disease Control and Prevention, designed to
provide national estimates of the health and nutritional status of
the United States’ civilian, non-institutionalized population. For
comparison with the SCCS data, we obtained data for 2,567
participants in the NHANES III database with characteristics
similar to the SCCS population: 40 to 79 years of age, living in the
southeastern region of the US, being non-Hispanic white or nonHispanic black, having a plasma selenium measure, and not being
pregnant. We compared only plasma selenium concentration since
NHANES III does not report SEPP1 or GPX3 data.

Statistical Analyses
Among 383 study participants, 377 had selenium, 383 had
SEPP1, and 366 had GPX3 plasma concentrations measured, and
all participants were characterized by demographic and lifestyle
variables according to race groups (Table 1). The t test and analysis
of variance (ANOVA) models were used to test the equality in the
mean values for the selenium biomarkers across demographic and
lifestyle variables (Table 2). Tukey’s post hoc analysis for multiple
comparisons was used to determine the significant mean differences
for more than two levels of the demographic and lifestyle variables.
Correlations between the selenium biomarkers were analyzed using
the Pearson correlation coefficient (Table 3).
The 25th, 50th, and 75th selenium biomarker percentiles were
used as cut-off points to establish quartile distributions (Table 4).
Multivariate logistic regression models for the biomarkers were
then utilized to calculate the odds ratios and 95% CIs for blacks vs.
whites at the higher quartiles (Q2, Q3, and Q4), using the lowest
quartile (Q1) as the reference. All other demographic (sex, age,
education level, household annual income, and BMI) and lifestyle
(smoking status, fruit and vegetable intake, meat and fish intake,
and living on farm) variables were adjusted in these models. The
Mantel-Haenszel trend test was used to test the linear trend in
odds ratios across the quartiles by race.
The mean value and standard deviation of SEPP1 and GPX3
within each quartile of selenium were calculated (Table 5), and
significant differences were determined by the t test.
The plasma selenium of the SCCS participants was compared
with plasma selenium in the NHANES III sample (Table 6).
Selenium concentration means were calculated within each group
categorized by race, sex, age, education level, household annual
income, and BMI, by using the Surveymeans program in SAS
after weighting of the NHANES III sample. The t test was used to
compare the mean difference between the SCCS and the
NHANES III participants.
To compare the selenium biomarkers with the dietary selenium
intakes in 351 participants who had both biomarker and dietary
data, the Pearson correlation coefficient (r) was used (Table 7).
After excluding 3 participants with missing covariate information,
an adjusted Pearson correlation coefficient (adjusted r) was
computed controlling for potential confounding by age (years,
continuous), BMI (kg/m2, continuous), race (black and white), sex
(male and female), household annual income (#$15,000; $15,001,$25,000; $25,001-,$50,000; and .$50,001), education level
(,high school, high school, .high school), (smoking status (nonsmoker, former smoker, current smoker), and living on a farm or
in an urban area (discrete). The sample was divided into two
groups below or above the 10th percentile of the daily selenium
intake (#57 mg/day) using the US RDA set at 55 mg/day as a
criterion [48]. The Pearson correlation coefficients (r, adjusted r)
were applied to test the linear relationship between the plasma
selenium concentrations with estimated daily selenium intakes for
the two selenium intake groups.
Statistical analyses were performed using SAS version 9.2 (SAS
Institute, Cary, NC). All statistical tests were based on a two-sided
probability, and p,0.05 was considered significant.

Selenium Biomarker Measures
Blood samples for SCCS participants were collected in two 10ml tubes, one with EDTA preservative, from non-fasting study
subjects at baseline at the CHCs. The vast majority (.95%) of
blood samples were processed at Vanderbilt University within
24 hours of collection, separated into aliquots of serum, plasma,
red blood cells, buffy coat, and clot, using standard techniques,
and kept frozen at 280uC. A plasma aliquot was used for the
selenium biomarker assays.
Plasma selenium status was assessed using the three biomarkers
of selenium status in our laboratory at Vanderbilt University,
Nashville:
(i) Selenium was measured fluorometrically, using methods of
Koh and Benson [42], as modified by Sheehan and Gao [43], and
expressed as mg/L (mmol/L).
(ii) SEPP 1 was measured by ELISA and expressed as mg/L. A
standard curve using purified human selenoprotein P was used for
calibration daily [44], and
(iii) GPX3 activity was expressed as U/L. One unit equals one
mmol NADPH oxidized per minute [32]. The method measures
the rate of oxidation of NADPH by glutathione peroxidase, using
0.25 mM H2O2 as substrate in the presence of 2 mM GSH.
Within NHANES III, plasma selenium was measured by atomic
absorption spectrophotometry. It has been shown before that there
is no difference in measurement outcomes between atomic
absorption spectrophotometry and the fluorometric method used
by Burk and Hill [31], [43], [45].

Dietary Selenium Intake
Daily dietary selenium intakes (mg/day) in SCCS participants
were estimated using the 89-item Food Frequency Questionnaire
(FFQ), developed empirically to include an optimal number and
selection of foods that would capture the main sources of energy
and key nutrient intakes in the SCCS population [46]. Selenium
content in food items eaten was estimated based on sex-, race-, and
census region-specific food lists using 24-hour recall data from
NHANES III, NHANES 1999–2000, NHANES 2001–2002,
NHANES 2003–2004, and the Continuing Survey of Food
Intakes by Individuals (CSFII 1994–96). This approach enabled
estimation of selenium intake tailored to the participant characteristics and to the southern diets typically eaten by potential
SCCS black and white participants [47]. An estimate of selenium
intake was available for all SCCS participants with measured
plasma selenium biomarkers, but dietary selenium estimates were
not available for NHANES III participants.

PLOS ONE | www.plosone.org

Results
Characteristics of the SCCS Study Population
By design, the present sample was balanced by race (black,
n = 191 and white, n = 192), sex (male and female; 50% each),
obesity status (BMI-18.3-24.9, 25.0–29.9, 30.0–44.9 kg/m2; 33%
in each category), and smoking status (non-smoker, former smoker,
current smoker; 33% in each category). This balance was present
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Table 2. Mean difference by sociodemographic and lifestyle variables for selenium biomarkers among SCCS participants.

Selenium (mg/L)

Demographics

SEPP1 (mg/L)

GPX3 (U/L)

N

Mean

(SD)

p value

N

Mean

(SD)

p value

N

Mean

(SD)

p value

White

188

117.6

(17.7)

0.082

191

4.7

(1.0)

0.006

184

132.4

33.5

0.320

Black

189

114.6

(15.1)

192

4.4

(1.1)

182

135.8

33.3

190

4.7

(1.1)

182

134.9

35.0

193

4.4

(1.1)

184

133.3

31.8

Race

Sex
Male

187

116.5

(15.1)

Female

190

115.6

(17.8)

0.591

0.010

40 to 49

165

113.8

(14.8)

168

4.3

(1.0)

160

136.9

34.5

50 to 59

120

120.1

(18.6)

122

4.8

(1.2)

116

133.0

33.8

60 to 79

92

114.9

(15.7)

93

4.7

(1.0)

90

130.5

30.7

, High School

119

116.5

(15.6)

124

4.7

(1.3)

119

135.3

35.7

High School

132

115.3

(17.6)

133

4.4

(1.0)

124

133.8

31.2

. High School

126

116.5

(16.2)

126

4.5

(0.9)

123

133.2

33.4

Less than
$15,000

224

115.8

(17.4)

229

4.5

(1.1)

219

133.8

33.7

$15,000 –
,$25,000

83

116.2

(15.7)

84

4.6

(1.1)

80

135.6

31.8

$25,000 –
,$50,000

52

116.5

(15.4)

52

4.4

(1.0)

50

133.8

35.5

$50,000 or
more

15

117.8

(11.8)

15

4.8

(0.9)

14

129.8

28.6

18.3 – 24.9

123

116.7

(20.1)

126

4.5

(1.3)

122

137.8

35.0

25.0 – 29.9

128

115.3

(14.5)

130

4.5

(1.1)

122

134.6

32.4

$30.0

126

116.2

(14.5)

127

4.7

(0.9)

122

129.8

32.5

0.636

Age group (years)
0.004

0.001

0.315

Education
0.811

0.079

0.880

Household Income
0.972

0.408

0.935

BMI (kg/m2)
0.775

0.188

0.171

Cigarette smoking
Non smoking

125

119.5

(18.7)

127

4.6

(1.2)

122

136.9

33.0

Former smoking

128

118.4

(16.2)

130

4.6

(1.0)

125

135.5

34.0

Current smoking

124

110.2

(12.5)

126

4.4

(1.0)

119

129.8

33.0

0–1

50

113.4

(14.9)

52

4.5

(0.9)

49

131.1

33.2

2–4

177

116.8

(16.1)

178

4.6

(1.2)

172

135.2

34.5

At least 5

150

116.1

(17.4)

153

4.5

(1.0)

145

133.8

32.2

0–1

191

116.1

(16.7)

194

4.5

(1.0)

186

136.1

35.2

2–4

159

116.4

(16.4)

162

4.6

(1.2)

153

132.4

31.4

At least 5

27

114.1

(15.9)

27

4.4

(1.2)

27

129.2

31.7

Yes

183

117.2

(15.5)

187

4.6

(0.9)

177

135.2

33.0

No

194

115.0

(17.4)

196

4.5

(1.2)

189

133.0

33.8

,0.001

0.250

0.215

Fruit and vegetable intake
(servings/day)
0.441

0.595

0.744

Meat and fish intake
(servings/day)
0.793

0.317

0.437

Living on farm
0.186

0.448

0.520

BMI - Body Mass Index; SEPP1 - Selenoprotein P; GPX3 - Glutathione Peroxidase.
doi:10.1371/journal.pone.0084972.t002

in these variables when categorized by race (Table 1). Additionally, education level (,high school, high school, .high school) was
roughly divided by one-third in each category. Other variables not
distributed evenly by race included: age, with 35% white and 53%
PLOS ONE | www.plosone.org

black between 40 and 49, 34% white and 30% black between 50
and 59, and 31% white and 18% black between 60 and 79 years of
age. The socio-economic status of the sample was low, with 61%
white and 59% black making less than $15,000; 21% white and
4
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whites (114.6 vs117.6, p = 0.08). No significant differences were
found by education, income, BMI, rural vs. urban residence, fruit
and vegetables, nor meat and fish consumption.
Selenoprotein P (SEPP1, mg/L). Significant differences in
plasma SEPP1 were found in race (p = 0.006), sex (p = 0.01), and
age groups (p = 0.001), with lower SEPP1 means among blacks
than whites, females than males, and those of age group 40–49
years, but with no monotonic trend with age (Table 2). The mean
level in blacks was 0.3 mg/L lower than in whites. There were no
significant differences by education, income, BMI, rural vs. urban
residence, fruit and vegetables, nor meat and fish consumption.
Glutathione Peroxidase (GPX3 Activity) (U/L). No significant associations were found between mean GPX3 and tested
demographic and lifestyle variables (Table 2). Also, the mean
GPX3 activity was not different between blacks and whites
(135.8 U/L vs. 132.4 U/L, p = 0.320).

Table 3. Relationships between plasma Selenium, (SEPP1),
and GPX3) in the SCCS sample.

r

p value

Se - SEPP1

0.49

,0.001

Se - GPX3

0.17

0.001

SEPP1 - GPX3

0.05

0.387

SEPP1 - Selenoprotein P; GPX3 - Glutathione Peroxidase.
doi:10.1371/journal.pone.0084972.t003

23% black, $15,000-,$25,000; 11% white and 16% black,
$25,000-,$50,000; and 7% white and 1% black, $50,000 or
more. Among dietary factors, we considered fruit and vegetable
intake, with 16% white and 11% black, 52% white and 41% black,
and 32% white and 47% black reporting an intake of 0–1, 2–4,
and at least 5 servings per day, respectively; and meat and fish
intake, with 58% white and 43% black, 39% white and 45% black,
and 3% white and 11% black reporting an intake of 0–1, 2–4, and
at least 5 servings per day, respectively. Fifty-seven percent of
whites and forty-one percent of blacks had lived in a rural
community or farm, and 43% whites and 59% blacks had lived in
an urban area.

Correlations of the plasma selenium biomarkers
Selenium plasma concentrations were significantly correlated
with SEPP1 (r = 0.49, p,0.001) and GPX3 (r = 0.17, p = 0.001),
but there was no correlation between SEPP1 and GPX3
concentration (r = 0.05, p = 0.39) (Table 3).

Black vs. White Differences in Selenium Biomarker Status
by Quartile Distribution
Selenium. Plasma selenium concentration ranged from
77.0 mg/L (0.98 mmol/L) to 192.6 mg/L (2.45 mmol/L) (mean 6
SD, 116.1616.5 mg/L (1.4760.21 mmol/L); median, 114.0 mg/L
(1.45 mmol/L)) (Table 4). The 1st quartile was from 77.0 to
,105.3 mg/L, the 2nd quartile from $105.4 to ,113.98 mg/L, the
3rd quartile from $114.0 to ,123.7 mg/L, and the 4th quartile from
$123.8 to 192.6 mg/L. The odds of having high plasma selenium
tended to be lower among blacks than whites (4th quartile), but the
difference was not significant (p for trend = 0.103).
Selenoprotein P (SEPP1). Plasma SEPP1 concentration
ranged from 1.1 mg/L to 12.4 mg/L (mean6SD, 4.661.1 mg/

Effect of SCCS Socio-Demographic and Lifestyle Factors
on Selenium Biomarkers
Selenium (mg/L). There were significant differences in
plasma selenium concentration across age groups (p = 0.004) and
smoking status groups (p,0.001) (Table 2). The plasma selenium
in the 40–49 year group was significantly lower than that in the
50–59 year group (p = 0.0016), but there was no monotonic trend
with age. Current smokers had plasma selenium significantly lower
than those who never smoked (p = 0.0001) and former smokers
(p = 0.0001). Blacks had a slightly lower plasma selenium than

Table 4. Plasma selenium concentration odds ratios for black and white Americans participating in the SCCS.

Quartile of plasma Selenium concentration
Q1 (low){
n

Odds ratio`

Q2
n

Q3
Odds ratio

n

Q4 (high)
Odds ratio

n

Odds ratio

mean (SD)

median (range)

p value

Selenium (mg/L)
Range

(77.0–105.3)

(105.4–113.9)

(114.0–123.7)

(123.8–192.6)

116.1 (16.5)

114.0 (77.0–192.6)

White

44

1.0

41

1.0

50

1.0

53

1.0

117.6 (17.7)

115.8 (77.0–192.6)

Black

50

1.0

54

1.1 (0.6 2.0)

43

0.9 (0.5 1.6)

42

0.7 (0.4 1.4)

114.6 (15.1)

113.1 (82.9–168.0)

0.103

Selenoprotein P (mg/L) (SEPP1)
Range

(1.1–3.9)

(3.9–4.5)

(4.5–5.1)

(5.1–12.4)

4.6 (1.1)

4.5 (1.1–12.4)

White

33

1.0

49

1.0

53

1.0

56

1.0

4.7 (1.0)

4.6 (2.2–9.4)

Black

62

1.0

45

0.5 (0.3 0.9)

45

0.4 (0.2 0.8)

40

0.4 (0.2 0.8)

4.4 (1.1)

4.3 (1.1–12.4)

131.7 (59.5–264.8)

0.002

Glutathione Peroxidase (GPX3) (U/L)
Range

(59.5–110.6)

(110.6–131.6)

(131.7–155.8)

(155.8–264.8)

134.1 (33.4)

White

48

1.0

54

1.0

41

1.0

41

1.0

132.4 (33.5)

125.4 (59.5–264.8)

Black

43

1.0

38

0.8 (0.4 1.5)

50

1.6 (0.9 3.1)

51

1.4 (0.7 2.6)

135.8 (33.3)

136.1 (62.3–242.9)

0.102

SEPP1 - Selenoprotein P; GPX3 - Glutathione Peroxidase
{Quartile cutpoints were based on the distribution for each selenium (Se) plasma concentration with whites and blacks combined.
`All models were adjusted for gender, age, education, household income, body mass index, smoking status, fruit and vegetable intake, meat and fish intake, and
living on farm.
doi:10.1371/journal.pone.0084972.t004
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Table 5. Mean SEPP1 and GPX3 plasma concentration according to quartiles of selenium concentration stratified by race.

Quartiles of the plasma selenium concentration
Biomarker

Q1 (low){

Q2

Q3

Q4 (high)

Range

(77.0–105.3)

(105.4–113.9)

(114.0–123.7)

(123.8–192.6)

Mean.(SD)

97.666.2

110.362.6

118.962.8

137.5613.8

Mean (SD)

Mean (SD)

Mean (SD)

Mean (SD)

Mean (SD)

4.160.8

4.560.9

4.860.8

5.261.1

n

44

41

50

53

Mean (SD)

3.960.8

4.361.1

4.460.8

5.061.0

n

50

54

43

42

Mean (SD)

Mean (SD)

Mean (SD)

Mean (SD)

Mean (SD)

126.8631.1

126.1625.7

132.5632.8

139.6639.4

n

43

39

48

51

Mean (SD)

122.2626.9

142.2636.1

131.7631.1

147.9633.3

n

48

52

42

39

Race

Selenium (mg/L)

SEPP1 (mg/L)
Whites

Blacks

GPX3 (U/L)
Whites

Blacks

SEPP1 - Selenoprotein P; GPX3 - Glutathione Peroxidase.
{Quartile cutpoints were based on the distribution for the Selenium concentration with whites and blacks combined.
doi:10.1371/journal.pone.0084972.t005

L; median, 4.5 mg/L) (Table 4). The odds of having high SEPP1
level were significantly lower for blacks than whites (p for trend
= 0.002).
Glutathione Peroxidase Activity (GPX3). Plasma GPX3
concentration ranged from 59.5 U/L to 264.8 U/L (mean6SD,
134.1633.4 U/L; median, 131.7 U/L) (Table 4). Blacks tended to
have higher GPX3 activity than whites, but the differences were
not significant (p for trend = 0.102).

Correlations between Daily Intakes of Selenium with
Selenium Biomarkers
No overall linear relationships between the three selenium
biomarkers and estimated daily selenium intake were found
(Table 7). When participants were divided into two subgroups
based upon whether their estimated daily dietary selenium intake
was #57 mg/day or .57 mg/day (10th percentile), a significant
linear relationship was found between SEPP1 and daily selenium
intake among participants in the #57 mg/day group (r = 0.41,
p,0.05; adjusted r = 0.56, P,0.005). None of the selenium
biomarkers was significantly related to higher levels (.57 mg/
day) of estimated daily selenium intake. The significance displayed
for GPX3 (adjusted r = 20.12, p,0.05) in the total sample was not
repeated in the two subgroups.

Comparison of SEPP1 and GPX3 across Plasma Selenium
Quartiles
There was a significant difference in mean SEPP1 levels
(p = 0.0004) across plasma selenium quartiles 3 and 4, with SEPP1
levels rising monotonically with selenium concentration among
both blacks and whites (Table 5). There was a significant
difference between GPX3 levels across selenium quartiles 1 and
2 among blacks (p = 0.0022), but not significantly different
thereafter across the remaining quartiles for blacks or whites.

Discussion
In this new examination of three biomarkers of selenium status
(plasma selenium, SEPP1 and GPX3) in a low-income southeastern US population, we found that SEPP1 provides the most
discrimination in identifying those with high vs. low selenium
status and in detecting differences between blacks and whites. We
compared plasma selenium results in our study with the NHANES
III southern regional population sample and found that plasma
selenium levels among the SCCS participants were slightly or
significantly lower than the NHANES III population within the
strata of some demographic variables (Table 6).
Since the NHANES III did not measure SEPP1, we compared
its concentration in the SCCS population with the baseline values
from the 81 healthy adults (mean age 36 years, 73% female)
entering a selenium supplementation trial at Vanderbilt University
[31]. The overall mean values in the SCCS were lower for
selenium (116 vs.121 mg/L, (1.47 vs. 1.54 mmol/L) p,0.002)),
SEPP1 (4.5 vs. 5.3 mg/L, p,0.0001), and GPX3 activity (134 vs.
159 U/L, p,0.0001). It is possible that these differences were
associated with the lower SES and race differences between the
SCCS and Vanderbilt trial participants.

Comparison of SCCS and NHANES III Mean Selenium
Levels
The average plasma selenium concentration in SCCS was
significantly lower than that reported by NHANES III for the
southeastern US (p = 0.023) (Table 6). The lower concentrations
held among both blacks and whites and men and women and in
most remaining demographic strata, with the largest SCCS vs.
NHANES III differences ($6 mg/L (0.08 mmol/L) among males
(p = 0.015), in those aged 40–49 years of age (p,0.001), those with
greater than a high school education (p,0.001), and those with
normal BMI (p = 0.021). However, there were no significant
differences between the other SCCS and NHANES III variables.
Within NHANES III, mean selenium concentration was lower
among blacks than whites (p = 0.002) and females than males
(p = 0.001), and showed stronger gradients of increasing levels with
rising education and income than in the SCCS. Within the SCCS,
significant differences by race and gender were reflected in the
SEPP1, and not the selenium, measures (Table 2).
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Table 6. Comparison of plasma selenium concentration between the SCCS and NHANES III (1988–1994) participants.

Selenium (mg/L)
SCCS*

t

p-value

NHANES III

N

Mean (SD)

N

Mean (SD)

Whites

188

117.6 (17.7)

1472

121.5 (33.7)

1.6

0.118

Blacks

189

114.6 (15.1)

1095

117.4 (32.4)

1.2

0.238

Race

Sex
Male

187

116.5 (15.1)

1258

122.4 (32.6)

2.4

0.015

Female

190

115.6 (17.8)

1309

119.4 (29.4)

1.7

0.081

40–49

165

113.8 (14.8)

771

121.7 (19.7)

4.9

,0.001

50–59

120

120.1 (18.6)

604

121.6 (26.0)

0.6

0.555

60–79

92

114.9 (15.7)

1192

119.3 (45.6)

0.9

0.357

,High School

119

116.5 (15.6)

1134

118.7 (38.5)

0.6

0.528

High School

132

115.3 (17.6)

737

120.1 (30.5)

1.8

0.081

.High School

126

116.5 (16.2)

647

123.7 (15.2)

4.8

,0.001

Less than $15,000

224

115.8 (17.4)

785

117.1 (50.7)

0.4

0.706

$15,000–,$25,000

83

116.2 (15.7)

523

118.6 (17.6)

1.2

0.228

Age group (years)

Education

Household Income

$25,000–,$50,000

52

116.5 (15.4)

649

122.2 (30.1)

1.4

0.177

$50,000+

15

117.8 (11.8)

371

124.1 (18.1)

1.3

0.187

18.3–24.9

123

116.7 (20.1)

846

122.5 (26.7)

2.3

0.021

25.0–29.9

128

115.3 (14.5)

954

120.3 (33.2)

1.7

0.090

$30.0

126

116.2 (14.5)

732

119.3 (25.1)

1.3

0.183

All

377

116.1 (16.5)

2567

120.9 (40.5)

2.3

0.023

BMI (kg/m2)

NHANES III: 40–79 yrs, South region of US.; BMI - Body Mass Index.
doi:10.1371/journal.pone.0084972.t006

Prior research assessing SEPP1 has been limited. Burk and
colleagues reported an SEPP1 concentration of 5.360.9 mg/L
among healthy adults participating in the Vanderbilt trial [20],
[31], and Saito et al. [49] reported 5.361.1 mg/L plasma SEPP1
in 73 healthy Japanese. Hurst et al [50] reported that in a 12-week
supplementation trial, mean SEPP1 in 119 healthy British men
and women aged 50–64 years of age increased from a
4.9960.80 mg/ml at baseline to 6.1760.85, 6.7361.01 and
6.5960.64 mg/ml depending on the supplemental selenomethionine dose (50, 100, and 200 mg, respectively). These figures are
within the range of normal by the Burk and Xia studies. Xia et al.
[33] also reported that plasma SEPP1 was maximized in deficient
Chinese at similar levels (from 4.961.1 to 5.661.1 mg/L) (n = 14/
group) when supplemented with 35, 55, 79, 102, and 125 mg/day
selenomethionine, over 4 to 40 weeks. The time of optimization
varied with the dose and length of supplementation. In our study
with the largest population sample reported to date in the US
(n = 383), SEPP1 ranged from 1.0 to 12.4 mg/L, with a mean level
of 4.661.1 mg/L, and half the participants having SEPP1 at or
below 4.5 mg/L.
SEPP1 and GPX3 are the only two known plasma selenoproteins, with SEPP1 representing over 50% of plasma selenium, and
GPX3 10–30% [51]; more recent work by Combs et al [52]
PLOS ONE | www.plosone.org

Table 7. Correlation and partial Pearson correlation
coefficients testing the strength of the linear association
between daily selenium intake and three plasma selenium
biomarkers in SCCS participants.

Selenium

SEPP1

GPX3

Total sample (N = 351)
Crude r

0.01

20.01

20.06

Adjusted r{

0.00

20.02

20.12*

Daily selenium intake #57 (mg/day)(N = 36) group
Crude r

0.31

0.41*

20.04

Adjusted r{

0.36

0.56**

0.05

Daily selenium intake .57 (mg/day)(N = 315) group
Crude r

0.00

20.03

20.04

Adjusted r{

20.01

20.03

20.11

Adjusted r{: adjusted for age, BMI (continuous), race, gender, education,
household annual income, smoking status, and living on a farm (discrete).
*: p,0.05; **: p,0.005.
BMI - Body Mass Index; SEPP1 - Selenoprotein P; GPX3 - Glutathione Peroxidase.
doi:10.1371/journal.pone.0084972.t007
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indicate that these values may be closer to 34% and 20%,
respectively. SEPP1, an extracellular protein produced in the liver
is believed to be important in performing specific transport
functions from the liver to peripheral tissues and in protecting
against oxidative injury [33], [49], [51], [53]. GPX3 is a plasma
protein synthesized in the proximal tubular cells of the kidney,
reducing hydroperoxides to harmless products (water and alcohol)
[33], [51]. Both plasma SEPP1 and GPX3 are depressed in
selenium deficiency and reach a plateau when they achieve their
optimal functional activity [53]. The levels of maximization/
optimization vary by biomarker, amount of selenium available,
and time required to perform their specific functions [33].
The SEPP1 in plasma has been postulated to be a more
appropriate measure of selenium nutritional status than either
plasma selenium or plasma GPX3 due to its need for higher levels
of selenium for optimization [54]. Because of its transport
function, SEPP1 is believed to ‘‘fill up body selenium pools
sequentially’’ [33], so would be a more sensitive overall indicator
than GPX3, which is synthesized in the kidney [33], [54]. There is
considerable uncertainty, however, regarding the selenium concentration needed to achieve maximization of SEPP1 or GPX3
(i.e. concentrations associated with adequate selenium nutritional
status), and whether these vary across black or white populations.
Selenium levels for GPX3 maximization have been reported to
vary from 40–200 mg/L (0.51–2.54 mmol/L) [55]; 70–100 mg/L
(0.89–1.27 mmol/L) [56]; 80–90 mg/L (1.02–1.14 mmol/L) [33];
91–122 mg/L (1.16–1.55 mmol/L) [57]; and 89–114 mg/L (1.13–
1.45 mmol/L) [16], but comparable data for SEPP1 are sparse.
While our results are not robust enough to demonstrate cut-off
points for maximization of either GPX3 or SEPP1, we found that
SEPP1 levels rose monotonically across ascending plasma
selenium quartiles in blacks and whites, meaning possibly that
SEPP1 was increasing towards, but not achieving, optimization in
these subjects (Table 5). On the other hand, the GPX3 levels in
blacks rose significantly from selenium quartile 1 to 2, then
dropped and rose again (non-significantly) in quartile 4, while in
whites, they rose non-significantly to quartile 4. These patterns
might be perhaps suggestive of maximization of SEPP1 and GPX3
at different time points at selenium concentrations above 100 mg/
L (the upper bound level of selenium quartile 1), with possible
differences by race.
Using plasma selenium cutoffs of 80, 90, 105, and 114 mg/L as
potential levels for GPX3/SEPP1 maximization, the proportions
of the SCCS sample that may be considered to have insufficient
selenium status for functional activity would be 1%, 5%, 25% and
50% respectively. Blacks tended to have higher insufficiency
percentages than whites at 90, 105, and 114 mg/L (6vs.3%,
28vs.24%, and 55vs.45% respectively). Furthermore, at selenium
levels above 105 mg/L (1.33 mmol/L), the mean SEPP1 concentrations for both blacks and whites in the SCCS were below
5.3 mg/L (the US normal level) (Table 4) [54], indicating that
SEPP1 had not been maximized, and raising the possibility that a
marginal selenium insufficiency, by the SEPP1 measure, may not
be uncommon in these populations.

Among the biomarkers, SEPP1 showed the strongest racial
differences, with blacks having mean SEPP1 significantly lower
than whites (p = 0.006) (Table 2). We also found that SEPP1 levels
varied significantly by sex and age groups. Plasma selenium was
marginally lower among blacks than whites and significantly lower
among smokers than non-smokers, and younger (39–49 years old)
age groups. GPX3 activity was not associated with race, gender,
age, or smoking status. Prior NHANES III data analyses reported
lower plasma selenium levels among blacks than whites, females
than males, and smokers than non-smokers [24], [58], [59]. We
confirmed that these patterns held within a subgroup of NHANES
III participants living in the southeastern US. In our study, plasma
selenium levels were significantly associated with both SEPP1 and
GPX3, while SEPP1 was not correlated with GPX3, suggesting
separate functions for these selenoproteins.
Although none of the biomarkers showed an overall association
with estimated daily dietary selenium intake, we found that SEPP1
was positively correlated with selenium intake in the subset of
SCCS participants with intake #57 mg/day (10th percentile crude
r = 0.41, p,0.05; adjusted r = 0.56, p,0.005) (Table 7). Our
findings showing SEPP1 association with race, sex, and lower
dietary selenium intake suggest that SEPP1 may be the most
sensitive biomarker of selenium status in our study population.
These findings are consistent with previous reports by Burk and
colleagues (20, 31, 33) who concluded that SEPP1 is the most
sensitive predictor of selenium nutritional status.

Implications and Conclusions
The primary purpose of this study was to determine whether
there may be variation in selenium status and to provide clues to
differentials in indications of selenium insufficiency among black
and white participants in the SCCS. This study demonstrated the
feasibility of assessing selenium status using three plasma selenium
biomarkers in a representative sample of low income black and
white adults. SEPP1 values in this group were slightly below those
in more affluent strata [30], suggesting that there may be marginal
selenium deficiency in more than half of the SCCS population.
The association of selenium nutritional status with plasma SEPP1
was higher than with selenium and GPX3. This suggests that
future studies, including planned assessments of an association of
baseline selenium status with cancer incidence among SCCS
participants focus on this biomarker.
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